ACCF/AHA/SCAI 2013 update of the clinical competence statement on coronary artery interventional procedures: A report of the American College of Cardiology Foundation/American Heart Association/American College of Physicians Task Force on Clinical Competence and Training (Writing Committee to Revise the 2007 Clinical Competence Statement on Cardiac Interventional Procedures)

Circulation

Volumn 128, Issue 4, 2013, Pages 436-472

  Harold, John G ^a   Bass, Theodore A ^a   Bashore, Thomas M ^a   Brindis, Ralph G ^a   Brush, John E ^a   Burke, James A ^a   Dehmer, Gregory J ^a   Deychak, Yuri A ^a   Jneid, Hani ^a   Jollis, James G ^a   Landzberg, Joel S ^a   Levine, Glenn N ^a   McClurken, James B ^a   Messenger, John C ^a   Moussa, Issam D ^a   Muhlestein, J Brent ^a   Pomerantz, Richard M ^a   Sanborn, Timothy A ^a   Sivaram, Chittur A ^a   White, Christopher J ^a   Williams, Eric S ^a   Jacobovitz, Shalom ^a   Oetgen, William J ^a   May, Charlene L ^a   Phoubandith, Dawn R ^a   Ronan, Grace D ^a   Barrett, Erin A ^a   Arnett, Donna ^a   Brown, Nancy ^a   Robertson, Rose Marie ^a   Whitman, Gayle R ^a   Bezanson, Judy L ^a   Linsky, Norm ^a   Harder, Joel ^a   more..

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADVERSE OUTCOME; AGE; ANGIOCARDIOGRAPHY; ARTERIOVENOUS FISTULA; ARTICLE; ATHERECTOMY DEVICE; BALLOON CATHETER; CARDIOGENIC SHOCK; CARDIOLOGIST; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; CERTIFICATION; CHRONIC LUNG DISEASE; CLINICAL COMPETENCE; COMORBIDITY; CONFIDENTIALITY; CONGESTIVE HEART FAILURE; CONTINUING EDUCATION; CONTRAST INDUCED NEPHROPATHY; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY BYPASS SURGERY; CORONARY ARTERY DISEASE; CORONARY ARTERY FISTULA; CORONARY ARTERY PERFORATION; CORONARY STENT; DEEP VEIN THROMBOSIS; EMERGENCY SURGERY; EVIDENCE BASED PRACTICE; FALSE ANEURYSM; GLOMERULUS FILTRATION RATE; HEART ARREST; HEART CATHETERIZATION; HEART MUSCLE ISCHEMIA; HEART TAMPONADE; HEART VENTRICLE ARRHYTHMIA; HEART VENTRICLE TACHYCARDIA; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY; LOW VOLUME HOSPITAL; MEDICAL EDUCATION; MORTALITY; OUTCOME ASSESSMENT; PATIENT CARE; PERCUTANEOUS CORONARY INTERVENTION; PERIPHERAL VASCULAR DISEASE; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROFESSIONAL KNOWLEDGE; QUALITY CONTROL; RETROPERITONEAL HEMORRHAGE; RISK ASSESSMENT; RISK FACTOR; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; STENT THROMBOSIS; THROMBUS ASPIRATION; TOTAL QUALITY MANAGEMENT; TRANSIENT ISCHEMIC ATTACK; TRANSLUMINAL CORONARY ANGIOPLASTY;

AHA SCIENTIFIC STATEMENTS; ANGIOPLASTY, BALLOON, CORONARY; CLINICAL COMPETENCE; CORONARY DISEASE; PEER REVIEW, HEALTHCARE; PERCUTANEOUS CORONARY INTERVENTION; QUALITY ASSURANCE; QUALITY IMPROVEMENT;

AMERICAN HEART ASSOCIATION; CARDIOLOGY; CLINICAL COMPETENCE; CORONARY ARTERY DISEASE; HUMANS; MYOCARDIAL REPERFUSION; PHYSICIANS; UNITED STATES;

EID: 84880723988     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIR.0b013e318299cd8a     Document Type: Article

References (168)

1. King SB 3rd, Aversano T, Ballard WL, et al. ACCF/AHA/SCAI 2007 update of the clinical competence statement on cardiac interventional procedures: a report of the American College of Cardiology Foundation/American Heart Association/American College of Physicians Task Force on Clinical Competence and Training. Circulation. 2007;116:98-124.
2. Levine GN, Bates ER, Blankenship JC, et al. 2011 ACCF/AHA/SCAI guideline for percutaneous coronary intervention: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions. Circulation. 2011;124:e574-651.
3. ACGME Program Requirements for Graduate Medical Education in Interventional Cardiology (Internal Medicine). Available at: http://www. acgme.org/acgmeweb/Portals/0/PFAssets/ProgramRequirements/152-interventional- card-int-med-07012012-1-YR.pdf. Accessed October 12, 2012.
4. Beller GA, Bonow RO, Fuster V. ACCF 2008 recommendations for training in adult cardiovascular medicine core cardiology training (COCATS 3) (revision of the 2002 COCATS training statement). J Am Coll Cardiol. 2008;51:335-8.
5. Gruentzig A. Percutaneous dilatation of experimental coronary artery stenosis: description of a new catheter system. Klin Wochenschr. 1976;54:543-5.
6. Gruentzig A. Transluminal dilatation of coronary-artery stenosis. Lancet. 1978;1:263.
7. Serruys PW, de Jaegere P, Kiemeneij F, et al. Benestent Study Group. A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. N Engl J Med. 1994;331:489-95. (Pubitemid 24256751)
8. Holmes DR Jr, Leon MB, Moses JW, et al. Analysis of 1-year clinical outcomes in the SIRIUS trial: a randomized trial of a sirolimus-eluting stent versus a standard stent in patients at high risk for coronary restenosis. Circulation. 2004;109:634-40. (Pubitemid 38198871)
9. Kim HI, Ishihara K, Lee S, et al. Tissue response to poly(L-lactic acid)-based blend with phospholipid polymer for biodegradable cardiovascular stents. Biomaterials. 2011;32:2241-7.
10. Navarese EP, Kubica J, Castriota F, et al. Safety and efficacy of biodegradable vs. durable polymer drug-eluting stents: evidence from a metaanalysis of randomised trials. EuroIntervention. 2011;7:985-94.
11. Serruys PW, Morice MC, Kappetein AP, et al. Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease. N Engl J Med. 2009;360:961-72.
12. Ferreiro JL, Angiolillo DJ. New directions in antiplatelet therapy. Circ Cardiovasc Interv. 2012;5:433-45.
13. Wallentin L, Becker RC, Budaj A, et al. Ticagrelor versus clopidogrel in patients with acute coronary syndromes. N Engl J Med. 2009;361:1045-57.
14. Wiviott SD, Braunwald E, McCabe CH, et al. Prasugrel versus clopidogrel in patients with acute coronary syndromes. N Engl J Med. 2007;357:2001-15. (Pubitemid 350106708)
15. Escaned J, Gonzalo N. Lessons learned from advanced intracoronary imaging in patients with acute myocardial infarction. J Cardiovasc Med (Hagerstown). 2011;12:868-77.
16. Tonino PA, De Bruyne B, Pijls NH, et al. Fractional flow reserve versus angiography for guiding percutaneous coronary intervention. N Engl J Med. 2009;360:213-24.
17. De Bruyne B, Pijls NH, Kalesan B, et al. Fractional flow reserve-guided PCI versus medical therapy in stable coronary disease. N Engl J Med. 2012;367:991-1001.
18. Naidu SS. Novel percutaneous cardiac assist devices: the science of and indications for hemodynamic support. Circulation. 2011;123:533-43.
19. Kimmel SE, Localio AR, Krone RJ, et al. The effects of contemporary use of coronary stents on in-hospital mortality. J Am Coll Cardiol. 2001;37:499-504.
20. Winchester DE, Wen X, Brearley WD, et al. Efficacy and safety of glycoprotein IIb/IIIa inhibitors during elective coronary revascularization: a meta-analysis of randomized trials performed in the era of stents and thienopyridines. J Am Coll Cardiol. 2011;57:1190-9.
21. Desai NR, Bhatt DL. The state of periprocedural antiplatelet therapy after recent trials. J Am Coll Cardiol Intv. 2010;3:571-83.
22. Bavry AA, Kumbhani DJ, Bhatt DL. Role of adjunctive thrombectomy and embolic protection devices in acute myocardial infarction: a comprehensive meta-analysis of randomized trials. Eur Heart J. 2008;29:2989-3001.
23. Baim DS, Wahr D, George B, et al. Randomized trial of a distal embolic protection device during percutaneous intervention of saphenous vein aorto-coronary bypass grafts. Circulation. 2002;105:1285-90. (Pubitemid 34260417)
24. Smith SC Jr, Dove JT, Jacobs AK, et al. ACC/AHA guidelines for percutaneous coronary interventions (revision of the 1993 PTCA guidelines): a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2001;103: 3019-41.
25. Smith SC Jr, Feldman TE, Hirshfeld JW Jr, et al. ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2006;47:e1-121.
26. Nakamura S, Hall P, Gaglione A, et al. High pressure assisted coronary stent implantation accomplished without intravascular ultrasound guidance and subsequent anticoagulation. J Am Coll Cardiol. 1997;29: 21-7. (Pubitemid 27028715)
27. Sonoda S, Morino Y, Ako J, et al. Impact of final stent dimensions on longterm results following sirolimus-eluting stent implantation: serial intravascular ultrasound analysis from the SIRIUS trial. J Am Coll Cardiol. 2004;43:1959-63. (Pubitemid 38686788)
28. Alpert JS, Thygesen K, Antman E, et al. Myocardial infarction redefined: a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the Redefinition of Myocardial Infarction. J Am Coll Cardiol. 2000;36:959-69.
29. Thygesen K, Alpert JS, White HD, et al. Universal definition of myocardial infarction. Circulation. 2007;116:2634-53. (Pubitemid 350182388)
30. Thygesen K, Alpert JS, Jaffe AS, et al. ESC/ACCF/AHA/WHF expert consensus document: third universal definition of myocardial infarction. Circulation. 2012;126:2020-35.
31. Peterson ED, Dai D, DeLong ER, et al. Contemporary mortality risk prediction for percutaneous coronary intervention: results from 588,398 procedures in the National Cardiovascular Data Registry. J Am Coll Cardiol. 2010;55:1923-32.
32. Ellis SG, Shishehbor MH, Kapadia SR, et al. Enhanced prediction of mortality after percutaneous coronary intervention by consideration of general and neurological indicators. J Am Coll Cardiol Intv. 2011;4:442-8.
33. Kutcher MA, Klein LW, Ou FS, et al. Percutaneous coronary interventions in facilities without cardiac surgery on site: a report from the National Cardiovascular Data Registry (NCDR). J Am Coll Cardiol. 2009;54: 16-24.
34. Aggarwal A, Dai D, Rumsfeld JS, et al. Incidence and predictors of stroke associated with percutaneous coronary intervention. Am J Cardiol. 2009;104:349-53.
35. Dukkipati S, O'Neill WW, Harjai KJ, et al. Characteristics of cerebrovascular accidents after percutaneous coronary interventions. J Am Coll Cardiol. 2004;43:1161-7. (Pubitemid 38452590)
36. Feit F, Voeltz MD, Attubato MJ, et al. Predictors and impact of major hemorrhage on mortality following percutaneous coronary intervention from the REPLACE-2 trial. Am J Cardiol. 2007;100:1364-9. (Pubitemid 47576015)
37. Manoukian SV, Feit F, Mehran R, et al. Impact of major bleeding on 30-day mortality and clinical outcomes in patients with acute coronary syndromes: an analysis from the ACUITY trial. J Am Coll Cardiol. 2007;49:1362-8. (Pubitemid 46476844)
38. Mehran R, Pocock SJ, Nikolsky E, et al. A risk score to predict bleeding in patients with acute coronary syndromes. J Am Coll Cardiol. 2010;55:2556-66.
39. Nikolsky E, Mehran R, Dangas G, et al. Development and validation of a prognostic risk score for major bleeding in patients undergoing percutaneous coronary intervention via the femoral approach. Eur Heart J. 2007;28:1936-45. (Pubitemid 47579535)
40. Ellis SG, Vandormael MG, Cowley MJ, et al. Multivessel Angioplasty Prognosis Study Group. Coronary morphologic and clinical determinants of procedural outcome with angioplasty for multivessel coronary disease: implications for patient selection. Circulation. 1990;82:1193-202.
41. Singh M, Lennon RJ, Holmes DR Jr, et al. Correlates of procedural complications and a simple integer risk score for percutaneous coronary intervention. J Am Coll Cardiol. 2002;40:387-93. (Pubitemid 34833150)
42. Tan K, Sulke N, Taub N, et al. Clinical and lesion morphologic determinants of coronary angioplasty success and complications: current experience. J Am Coll Cardiol. 1995;25:855-65.
43. Ryan TJ, Bauman WB, Kennedy JW, et al. Guidelines for percutaneous transluminal coronary angioplasty: a report of the American Heart Association/American College of Cardiology Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures (Committee on Percutaneous Transluminal Coronary Angioplasty). Circulation. 1993;88:2987-3007. (Pubitemid 23360229)
44. Krone RJ, Shaw RE, Klein LW, et al. Evaluation of the American College of Cardiology/American Heart Association and the Society for Coronary Angiography and Interventions lesion classification system in the current "stent era" of coronary interventions (from the ACC-National Cardiovascular Data Registry). Am J Cardiol. 2003;92:389-94. (Pubitemid 36959873)
45. Resnic FS, Normand SL, Piemonte TC, et al. Improvement in mortality risk prediction after percutaneous coronary intervention through the addition of a "compassionate use" variable to the National Cardiovascular Data Registry CathPCI Dataset: a study from the Massachusetts Angioplasty Registry. J Am Coll Cardiol. 2011;57:904-11.
46. Kimmel SE, Berlin JA, Strom BL, et al. Development and validation of simplified predictive index for major complications in contemporary percutaneous transluminal coronary angioplasty practice. J Am Coll Cardiol. 1995;26:931-8.
47. Krone RJ, Laskey WK, Johnson C, et al. A simplified lesion classification for predicting success and complications of coronary angioplasty. Am J Cardiol. 2000;85:1179-84. (Pubitemid 30232810)
48. Morice MC, Serruys PW, Kappetein AP, et al. Outcomes in patients with de novo left main disease treated with either percutaneous coronary intervention using paclitaxel-eluting stents or coronary artery bypass graft treatment in the Synergy Between Percutaneous Coronary Intervention with TAXUS and Cardiac Surgery (SYNTAX) trial. Circulation. 2010;121:2645-53.
49. Kappetein AP, Feldman TE, Mack MJ, et al. Comparison of coronary bypass surgery with drug-eluting stenting for the treatment of left main and/or three-vessel disease: 3-year follow-up of the SYNTAX trial. Eur Heart J. 2011;32:2125-34.
50. Serruys PW, Onuma Y, Garg S, et al. Assessment of the SYNTAX score in the Syntax study. EuroIntervention. 2009;5:50-6.
51. Bashore TM, Balter S, Barac A, et al. 2012 American College of Cardiology Foundation/Society for Cardiovascular Angiography and Interventions expert consensus document on cardiac catheterization laboratory standards update: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents. J Am Coll Cardiol. 2012;59:2221-305.
52. Patel MR, Dehmer GJ, Hirshfeld JW, et al. ACCF/SCAI/STS/AATS/AHA/ASNC/ HFSA/SCCT 2012 appropriate use criteria for coronary revascularization focused update: a report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force, Society for Cardiovascular Angiography and Interventions, Society of Thoracic Surgeons, American Association for Thoracic Surgery, American Heart Association, American Society of Nuclear Cardiology, and the Society of Cardiovascular Computed Tomography Imaging. J Am Coll Cardiol. 2012;59:857-81.
53. Aversano T, Aversano LT, Passamani E, et al. Thrombolytic therapy vs primary percutaneous coronary intervention for myocardial infarction in patients presenting to hospitals without on-site cardiac surgery: a randomized controlled trial. JAMA. 2002;287:1943-51. (Pubitemid 34309752)
54. Dehmer GJ, Blankenship J, Wharton TP Jr, et al. The current status and future direction of percutaneous coronary intervention without on-site surgical backup: an expert consensus document from the Society for Cardiovascular Angiography and Interventions. Catheter Cardiovasc Interv. 2007;69:471-8. (Pubitemid 46363845)
55. Melberg T, Nilsen DW, Larsen AI, et al. Nonemergent coronary angioplasty without on-site surgical backup: a randomized study evaluating outcomes in low-risk patients. Am Heart J. 2006;152:888-95. (Pubitemid 44632952)
56. Singh PP, Singh M, Bedi US, et al. Outcomes of nonemergent percutaneous coronary intervention with and without on-site surgical backup: a meta-analysis. Am J Ther. 2011;18:e22-28.
57. Moscucci M, Eagle KA, Share D, et al. Public reporting and case selection for percutaneous coronary interventions: an analysis from two large multicenter percutaneous coronary intervention databases. J Am Coll Cardiol. 2005;45:1759-65. (Pubitemid 40779853)
58. Hannan EL, Wu C, Walford G, et al. Volume-outcome relationships for percutaneous coronary interventions in the stent era. Circulation. 2005;112:1171-9. (Pubitemid 41216124)
59. Moscucci M, Rogers EK, Montoye C, et al. Association of a continuous quality improvement initiative with practice and outcome variations of contemporary percutaneous coronary interventions. Circulation. 2006;113:814-22.
60. Tiroch KA, Arora N, Matheny ME, et al. Risk predictors of retroperitoneal hemorrhage following percutaneous coronary intervention. Am J Cardiol. 2008;102:1473-6.
61. Mehran R, Aymong ED, Nikolsky E, et al. A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: development and initial validation. J Am Coll Cardiol. 2004;44:1393-9. (Pubitemid 39303939)
62. Mehta SK, Frutkin AD, Lindsey JB, et al. Bleeding in patients undergoing percutaneous coronary intervention: the development of a clinical risk algorithm from the National Cardiovascular Data Registry. Circ Cardiovasc Interv. 2009;2:222-9.
63. Luft HS, Bunker JP, Enthoven AC. Should operations be regionalized The empirical relation between surgical volume and mortality. N Engl J Med. 1979;301:1364-9. (Pubitemid 10170739)
64. Ryan TJ, Faxon DP, Gunnar RM, et al. Guidelines for percutaneous transluminal coronary angioplasty: a report of the American College of Cardiology/American Heart Association Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures (Subcommittee on Percutaneous Transluminal Coronary Angioplasty). Circulation. 1988;78:486-502.
65. Ryan TJ, Klocke FJ, Reynolds WA. Clinical competence in percutaneous transluminal coronary angioplasty: a statement for physicians from the ACP/ACC/AHA Task Force on Clinical Privileges in Cardiology. Circulation. 1990;81:2041-46.
66. Brindis RG, Weintraub WS, Dudley RA. Volume as a surrogate for percutaneous coronary intervention quality: is this the right measuring stick Am Heart J. 2003;146:932-4. (Pubitemid 37500761)
67. Khuri SF, Henderson WG. The case against volume as a measure of quality of surgical care. World J Surg. 2005;29:1222-9. (Pubitemid 41625963)
68. Hartz AJ, Kuhn EM, Kayser KL, et al. Assessing providers of coronary revascularization: a method for peer review organizations. Am J Public Health. 1992;82:1631-40.
69. Ritchie JL, Phillips KA, Luft HS. Coronary angioplasty: statewide experience in California. Circulation. 1993;88:2735-43. (Pubitemid 23360200)
70. Jollis JG, Peterson ED, DeLong ER, et al. The relation between the volume of coronary angioplasty procedures at hospitals treating Medicare beneficiaries and short-term mortality. N Engl J Med. 1994;331:1625-9. (Pubitemid 24372062)
71. Jollis JG, Peterson ED, Nelson CL, et al. Relationship between physician and hospital coronary angioplasty volume and outcome in elderly patients. Circulation. 1997;95:2485-91. (Pubitemid 27233113)
72. Hannan EL, Racz M, Ryan TJ, et al. Coronary angioplasty volume-outcome relationships for hospitals and cardiologists. JAMA. 1997;277:892-8. (Pubitemid 27123949)
73. Ho V. Evolution of the volume-outcome relation for hospitals performing coronary angioplasty. Circulation. 2000;101:1806-11. (Pubitemid 30213102)
74. Kimmel SE, Sauer WH, Brensinger C, et al. Relationship between coronary angioplasty laboratory volume and outcomes after hospital discharge. Am Heart J. 2002;143:833-40. (Pubitemid 34595341)
75. Epstein AJ, Rathore SS, Volpp KG, et al. Hospital percutaneous coronary intervention volume and patient mortality, 1998 to 2000: does the evidence support current procedure volume minimums J Am Coll Cardiol. 2004;43:1755-62. (Pubitemid 38622510)
76. Carey JS, Danielsen B, Gold JP, et al. Procedure rates and outcomes of coronary revascularization procedures in California and New York. J Thorac Cardiovasc Surg. 2005;129:1276-82. (Pubitemid 40804844)
77. Burton KR, Slack R, Oldroyd KG, et al. Hospital volume of throughput and periprocedural and medium-term adverse events after percutaneous coronary intervention: retrospective cohort study of all 17,417 procedures undertaken in Scotland, 1997-2003. Heart. 2006;92:1667-72. (Pubitemid 44629184)
78. Allareddy V, Allareddy V, Konety BR. Specificity of procedure volume and in-hospital mortality association. Ann Surg. 2007;246:135-9. (Pubitemid 47012218)
79. Zahn R, Gottwik M, Hochadel M, et al. Volume-outcome relation for contemporary percutaneous coronary interventions (PCI) in daily clinical practice: is it limited to high-risk patients Results from the Registry of Percutaneous Coronary Interventions of the Arbeitsgemeinschaft Leitende Kardiologische Krankenhausarzte (ALKK). Heart. 2008;94:329-35. (Pubitemid 351358967)
80. Lin HC, Lee HC, Chu CH. The volume-outcome relationship of percutaneous coronary intervention: can current procedure volume minimums be applied to a developing country Am Heart J. 2008;155:547-52.
81. Madan M, Nikhil J, Hellkamp AS, et al. Effect of operator and institutional volume on clinical outcomes after percutaneous coronary interventions performed in Canada and the United States: a brief report from the Enhanced Suppression of the Platelet glycoprotein IIb/IIIa Receptor with Integrilin Therapy (ESPRIT) study. Can J Cardiol. 2009;25:e269-72.
82. Post PN, Kuijpers M, Ebels T, et al. The relation between volume and outcome of coronary interventions: a systematic review and meta-analysis. Eur Heart J. 2010;31:1985-92.
83. Dehmer GJ, Weaver WD, Roe MT, et al. A contemporary view of diagnostic cardiac catheterization and percutaneous coronary intervention in the United States: a report from the CathPCI Registry of the National Cardiovascular Data Registry 2010 through June 2011. J Am Coll Cardiol. 2012;60:2017-31.
84. McGrath PD, Wennberg DE, Dickens JD Jr, et al. Relation between operator and hospital volume and outcomes following percutaneous coronary interventions in the era of the coronary stent. JAMA. 2000;284:3139-44. (Pubitemid 32039076)
85. Moscucci M, Share D, Smith D, et al. Relationship between operator volume and adverse outcome in contemporary percutaneous coronary intervention practice: an analysis of a quality-controlled multicenter percutaneous coronary intervention clinical database. J Am Coll Cardiol. 2005;46:625-32. (Pubitemid 41132688)
86. Minges KE, Wang Y, Dodson JA, et al. Physician annual volume and in-hospital mortality following percutaneous coronary intervention: a report from the NCDR: American Heart Association 2011 Annual Scientific Sessions. Circulation. 2011;124:A16550. Abstract.
87. Maroney J, Khan S, Powell W, et al. Current operator volumes of invasive coronary procedures in Medicare patients: implications for future manpower needs in the catheterization laboratory. Catheter Cardiovasc Interv. 2013;81:34-9.
88. Tsuchihashi M, Tsutsui H, Tada H, et al. Volume-outcome relation for hospitals performing angioplasty for acute myocardial infarction: results from the Nationwide Japanese Registry. Circ J. 2004;68:887-91. (Pubitemid 39410211)
89. Ohtsuka MT, Toyama M, Obara K, et al. Effect of hospital case volume on treatment and in-hospital outcomes in patients undergoing percutaneous coronary intervention for acute myocardial infarction. Results from the Ibaraki Coronary Artery Disease Study (ICAS) Registry. Int Heart J. 2008;49:249-60.
90. Shiraishi J, Kohno Y, Sawada T, et al. Effects of hospital volume of primary percutaneous coronary interventions on angiographic results and in-hospital outcomes for acute myocardial infarction. Circ J. 2008;72:1041-6. (Pubitemid 351957066)
91. Kumbhani DJ, Cannon CP, Fonarow GC, et al. Association of hospital primary angioplasty volume in ST-segment elevation myocardial infarction with quality and outcomes. JAMA. 2009;302:2207-13.
92. Tiefenbrunn AJ, Chandra NC, French WJ, et al. Clinical experience with primary percutaneous transluminal coronary angioplasty compared with alteplase (recombinant tissue-type plasminogen activator) in patients with acute myocardial infarction: a report from the Second National Registry of Myocardial Infarction (NRMI-2). J Am Coll Cardiol. 1998;31:1240-5.
93. Zahn R, Vogt A, Seidl K, et al. Balloon dilatation in acute myocardial infarct in routine clinical practice: results of the register of the Working Society of Leading Cardiologic Hospital Physicians in 4,625 patients. Z Kardiol. 1997;86:712-21.
94. Magid DJ, Calonge BN, Rumsfeld JS, et al. Relation between hospital primary angioplasty volume and mortality for patients with acute MI treated with primary angioplasty vs thrombolytic therapy. JAMA. 2000;284:3131-8. (Pubitemid 32039075)
95. Canto JG, Every NR, Magid DJ, et al. National Registry of Myocardial Infarction 2 Investigators. The volume of primary angioplasty procedures and survival after acute myocardial infarction. N Engl J Med. 2000;342:1573-80. (Pubitemid 30340504)
96. Cannon CP, Gibson CM, Lambrew CT, et al. Relationship of symptom-onset-to-balloon time and door-to-balloon time with mortality in patients undergoing angioplasty for acute myocardial infarction. JAMA. 2000;283:2941-7. (Pubitemid 30414505)
97. Vakili BA, Kaplan R, Brown DL. Volume-outcome relation for physicians and hospitals performing angioplasty for acute myocardial infarction in New York state. Circulation. 2001;104:2171-6. (Pubitemid 33043295)
98. Zahn R, Vogt A, Zeymer U, et al. In-hospital time to treatment of patients with acute ST elevation myocardial infarction treated with primary angioplasty: determinants and outcome. Results from the registry of percutaneous coronary interventions in acute myocardial infarction of the Arbeitsgemeinschaft Leitender Kardiologischer Krankenhausarzte. Heart. 2005;91:1041-6. (Pubitemid 41060011)
99. Srinivas VS, Hailpern SM, Koss E, et al. Effect of physician volume on the relationship between hospital volume and mortality during primary angioplasty. J Am Coll Cardiol. 2009;53:574-9.
100. Kuwabara H, Fushimi K, Matsuda S. Relationship between hospital volume and outcomes following primary percutaneous coronary intervention in patients with acute myocardial infarction. Circ J. 2011;75: 1107-12.
101. Vakili BA, Brown DL. Relation of total annual coronary angioplasty volume of physicians and hospitals on outcomes of primary angioplasty for acute myocardial infarction (data from the 1995 Coronary Angioplasty Reporting System of the New York State Department of Health). Am J Cardiol. 2003;91:726-8. (Pubitemid 36287469)
102. Spaulding C, Morice MC, Lancelin B, et al. Is the volume-outcome relation still an issue in the era of PCI with systematic stenting Results of the greater Paris area PCI registry. Eur Heart J. 2006;27:1054-60.
103. Shahian DM, Meyer GS, Yeh RW, et al. Percutaneous coronary interventions without on-site cardiac surgical backup. N Engl J Med. 2012;366:1814-23.
104. Keeley EC, Boura JA, Grines CL. Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials. Lancet. 2003;361:13-20. (Pubitemid 36050955)
105. Wharton TP Jr, McNamara NS, Fedele FA, et al. Primary angioplasty for the treatment of acute myocardial infarction: experience at two community hospitals without cardiac surgery. J Am Coll Cardiol. 1999;33:1257-65.
106. Ting HH, Raveendran G, Lennon RJ, et al. A total of 1,007 percutaneous coronary interventions without onsite cardiac surgery: acute and longterm outcomes. J Am Coll Cardiol. 2006;47:1713-21.
107. Wharton TP Jr. Nonemergent percutaneous coronary intervention with off-site surgery backup: an emerging new path to access. Crit Pathw Cardiol. 2005;4:98-106. (Pubitemid 40911247)
108. Dehmer GJ, Kutcher MA, Dey SK, et al. Frequency of percutaneous coronary interventions at facilities without on-site cardiac surgical backup: a report from the American College of Cardiology-National Cardiovascular Data Registry (ACC-NCDR). Am J Cardiol. 2007;99:329-32. (Pubitemid 46149551)
109. Carlsson J, James SN, Stahle E, et al. Outcome of percutaneous coronary intervention in hospitals with and without on-site cardiac surgery standby. Heart. 2007;93:335-8. (Pubitemid 46579524)
110. Zia MI, Wijeysundera HC, Tu JV, et al. Percutaneous coronary intervention with vs without on-site cardiac surgery backup: a systematic review and meta-analysis. Can J Cardiol. 2011;27:664-16.
111. Singh M, Holmes DR Jr, Dehmer GJ, et al. Percutaneous coronary intervention at centers with and without on-site surgery: a meta-analysis. JAMA. 2011;306:2487-94.
112. Singh M, Gersh BJ, Lennon RJ, et al. Outcomes of a system-wide protocol for elective and nonelective coronary angioplasty at sites without on-site surgery: the Mayo Clinic experience. Mayo Clin Proc. 2009;84:501-8.
113. Aversano T, Lemmon CC, Liu L. Outcomes of PCI at hospitals with or without on-site cardiac surgery. N Engl J Med. 2012;366:1792-802.
114. Pride YB, Canto JG, Frederick PD, et al. Outcomes among patients with ST-segment-elevation myocardial infarction presenting to interventional hospitals with and without on-site cardiac surgery. Circ Cardiovasc Qual Outcomes. 2009;2:574-82.
115. Yeh RW, Sidney S, Chandra M, et al. Population trends in the incidence and outcomes of acute myocardial infarction. N Engl J Med. 2010;362:2155-65.
116. Jollis JG, Granger CB, Henry TD, et al. Systems of care for ST-segmentelevation myocardial infarction: a report from the American Heart Association's Mission: Lifeline. Circ Cardiovasc Qual Outcomes. 2012;5:423-8.
117. Kansagra SM, Curtis LH, Anstrom KJ, et al. Trends in operator and hospital procedure volume and outcomes for percutaneous transluminal coronary angioplasty, 1996 to 2001. Am J Cardiol. 2007;99:339-43. (Pubitemid 46149555)
118. Jollis JG, Ancukiewicz M, DeLong ER, et al. Discordance of databases designed for claims payment versus clinical information systems: implications for outcomes research. Ann Intern Med. 1993;119:844-50. (Pubitemid 24012651)
119. Resnic FS, Welt FG. The public health hazards of risk avoidance associated with public reporting of risk-adjusted outcomes in coronary intervention. J Am Coll Cardiol. 2009;53:825-30.
120. The Leapfrog Group. Available at: http://www.leapfroggroup.org/. Accessed October 14, 2012.
121. The Leapfrog Group. Leapfrog Evidence-Based Hospital Referral Fact Sheet. Available at: http://www.leapfroggroup.org/media/file/Leapfrog-Evidence-based- Hospital-Referral-Fact-Sheet.pdf. Accessed October 14, 2012.
122. Wijns W, Kolh P, Danchin N, et al. Guidelines on myocardial revascularization. Eur Heart J. 2010;31:2501-55.
123. Fox KF. Simulation-based learning in cardiovascular medicine: benefits for the trainee, the trained and the patient. Heart. 2012;98:527-8.
124. De Ponti R, Marazzi R, Ghiringhelli S, et al. Superiority of simulator-based training compared with conventional training methodologies in the performance of transseptal catheterization. J Am Coll Cardiol. 2011;58:359-63.
125. Voelker W, Maier S, Lengenfelder B, et al. Improved quality of coronary diagnostics and interventions by virtual reality simulation. Herz. 2011;36:430-5.
126. Marco J, Holmes DR Jr. Simulation: present and future roles. J Am Coll Cardiol Intv. 2008;1:590-2.
127. Lipner RS, Messenger JC, Kangilaski R, et al. A technical and cognitive skills evaluation of performance in interventional cardiology procedures using medical simulation. Simul Healthc. 2010;5:65-74.
128. Klein LW, Uretsky BF, Chambers C, et al. Quality assessment and improvement in interventional cardiology: a position statement of the Society of Cardiovascular Angiography and Interventions, part 1: standards for quality assessment and improvement in interventional cardiology. Catheter Cardiovasc Interv. 2011;77:927-35.
129. Campeau L. Percutaneous radial artery approach for coronary angiography. Cathet Cardiovasc Diagn. 1989;16:3-7. (Pubitemid 19033502)
130. Kiemeneij F, Laarman GJ. Transradial artery Palmaz-Schatz coronary stent implantation: results of a single-center feasibility study. Am Heart J. 1995;130:14-21.
131. Lotan C, Hasin Y, Mosseri M, et al. Transradial approach for coronary angiography and angioplasty. Am J Cardiol. 1995;76:164-7.
132. Spaulding C, Lefevre T, Funck F, et al. Left radial approach for coronary angiography: results of a prospective study. Cathet Cardiovasc Diagn. 1996;39:365-70. (Pubitemid 26423982)
133. Wang L, Yang Y, Zhou Y, et al. Prevalence of transradial coronary angiography and intervention in China: report from the Transradial coronary intervention Registration Investigation in China (TRI-China). Int J Cardiol. 2010;145:246-7.
134. Rao SV, Ou FS, Wang TY, et al. Trends in the prevalence and outcomes of radial and femoral approaches to percutaneous coronary intervention: a report from the National Cardiovascular Data Registry. J Am Coll Cardiol Intv. 2008;1:379-86.
135. Feldman D, Swaminathan RV, Kaltenbach LA, et al. Adoption of radial access and comparison of outcomes to femoral approach in percutaneous coronary intervention in the United States: an updated report from the National Cardiovascular Data Registry (2007-2011): American Heart Association 2012 Annual Scientific Sessions. Circulation. 2012;126:A12423. Abstract.
136. Jolly SS, Yusuf S, Cairns J, et al. Radial versus femoral access for coronary angiography and intervention in patients with acute coronary syndromes (RIVAL): a randomised, parallel group, multicentre trial. Lancet. 2011;377:1409-20.
137. Cooper CJ, El-Shiekh RA, Cohen DJ, et al. Effect of transradial access on quality of life and cost of cardiac catheterization: a randomized comparison. Am Heart J. 1999;138:430-6. (Pubitemid 29428763)
138. Kindel M, Ruppel R. Hydrophilic-coated sheaths increase the success rate of transradial coronary procedures and reduce patient discomfort but do not reduce the occlusion rate: randomized single-blind comparison of coated vs. non-coated sheaths. Clin Res Cardiol. 2008;97:609-14.
139. Ball WT, Sharieff W, Jolly SS, et al. Characterization of operator learning curve for transradial coronary interventions. Circ Cardiovasc Interv. 2011;4:336-41.
140. Uhlemann M, Mobius-Winkler S, Mende M, et al. The Leipzig prospective vascular ultrasound registry in radial artery catheterization: impact of sheath size on vascular complications. J Am Coll Cardiol Intv. 2012;5:36-43.
141. Caputo RP, Tremmel JA, Rao S, et al. Transradial arterial access for coronary and peripheral procedures: executive summary by the Transradial Committee of the SCAI. Catheter Cardiovasc Interv. 2011;78:823-39.
142. Hirshfeld JW Jr, Banas JS Jr, Brundage BH, et al. American College of Cardiology training statement on recommendations for the structure of an optimal adult interventional cardiology training program: a report of the American College of Cardiology Task Force on Clinical Expert Consensus Documents. J Am Coll Cardiol. 1999;34:2141-7. (Pubitemid 30002678)
143. Dehmer GJ, Brindis RG. Quality of care in interventional cardiology. In: Topol EJ. editor. Textbook of Interventional Cardiology. Philadelphia, Pa: Saunders Elsevier, 2011:873-93.
144. Jacobs AK, Babb JD, Hirshfeld JW Jr, et al. Task Force 3: training in diagnostic and interventional cardiac catheterization. J Am Coll Cardiol. 2008;51:355-61.
145. Uretsky BF, Wang FW. Implementation and application of a continuous quality improvement (CQI) program for the cardiac catheterization laboratory: one institution's 10-year experience. Catheter Cardiovasc Interv. 2006;68:586-95. (Pubitemid 44546053)
146. Anderson HV, Shaw RE, Brindis RG, et al. Relationship between procedure indications and outcomes of percutaneous coronary interventions by American College of Cardiology/American Heart Association Task Force Guidelines. Circulation. 2005;112:2786-91. (Pubitemid 41641672)
147. Weintraub WS, Grau-Sepulveda MV, Weiss JM, et al. Prediction of long-term mortality after percutaneous coronary intervention in older adults: results from the National Cardiovascular Data Registry. Circulation. 2012;125:1501-10.
148. Hamburger JN, Walsh SJ, Khurana R, et al. Percutaneous coronary intervention and 30-day mortality: the British Columbia PCI risk score. Catheter Cardiovasc Interv. 2009;74:377-85.
149. Chowdhary S, Ivanov J, Mackie K, et al. The Toronto score for in-hospital mortality after percutaneous coronary interventions. Am Heart J. 2009;157:156-63.
150. Brown JR, DeVries JT, Piper WD, et al. Serious renal dysfunction after percutaneous coronary interventions can be predicted. Am Heart J. 2008;155:260-6.
151. Singh M, Peterson ED, Milford-Beland S, et al. Validation of the Mayo clinic risk score for in-hospital mortality after percutaneous coronary interventions using the National Cardiovascular Data Registry. Circ Cardiovasc Interv. 2008;1:36-44.
152. Singh M, Rihal CS, Lennon RJ, et al. Bedside estimation of risk from percutaneous coronary intervention: the new Mayo Clinic risk scores. Mayo Clin Proc. 2007;82:701-8. (Pubitemid 46878093)
153. Wu C, Hannan EL, Walford G, et al. A risk score to predict in-hospital mortality for percutaneous coronary interventions. J Am Coll Cardiol. 2006;47:654-60. (Pubitemid 43170859)
154. Douglas PS, Brindis RG. President's page: a question of quality: why national benchmarking J Am Coll Cardiol. 2006;47:1076-8.
155. Klein LW, Kolm P, Xu X, et al. A longitudinal assessment of coronary interventional program quality: a report from the American College of Cardiology-National Cardiovascular Data Registry. J Am Coll Cardiol Intv. 2009;2:136-43.
156. Dehmer GJ, Hirshfeld JW, Oetgen WJ, et al. CathKIT: improving quality in the cardiac catheterization laboratory. J Am Coll Cardiol. 2004;43:893-9. (Pubitemid 38296493)
157. Brindis RG, Fitzgerald S, Anderson HV, et al. The American College of Cardiology-National Cardiovascular Data Registry (ACC-NCDR): building a national clinical data repository. J Am Coll Cardiol. 2001;37:2240-5.
158. Brindis RG, Dehmer GJ. Continuous quality improvement in the cardiac catheterization laboratory: are the benefits worth the cost and effort Circulation. 2006;113:767-70.
159. Sigwart U. Non-surgical myocardial reduction for hypertrophic obstructive cardiomyopathy. Lancet. 1995;346:211-4.
160. Lyne JC, Kilpatrick T, Duncan A, et al. Long-term follow-up of the first patients to undergo transcatheter alcohol septal ablation. Cardiology. 2010;116:168-73.
161. Nagueh SF, Groves BM, Schwartz L, et al. Alcohol septal ablation for the treatment of hypertrophic obstructive cardiomyopathy: a multicenter North American registry. J Am Coll Cardiol. 2011;58:2322-8.
162. Sorajja P, Ommen SR, Holmes DR Jr, et al. Survival after alcohol septal ablation for obstructive hypertrophic cardiomyopathy. Circulation. 2012;126:2374-80.
163. Gersh BJ, Maron BJ, Bonow RO, et al. 2011 ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation. 2011;124:e783-831.
164. Herrmann HC, Baxter S, Ruiz CE, et al. Results of the Society of Cardiac Angiography and Interventions survey of physicians and training directors on procedures for structural and valvular heart disease. Catheter Cardiovasc Interv. 2010;76:E106-10.
165. Kim SS, Knight BP. Alcohol ablation for ventricular tachycardia: a distillation of modern cases. Heart Rhythm. 2008;5:69-70.
166. Sacher F, Sobieszczyk P, Tedrow U, et al. Transcoronary ethanol ventricular tachycardia ablation in the modern electrophysiology era. Heart Rhythm. 2008;5:62-8.
167. John RM, Stevenson WG. Catheter-based ablation for ventricular arrhythmias. Curr Cardiol Rep. 2011;13:399-406.
168. Warnes CA, Williams RG, Bashore TM, et al. ACC/AHA 2008 guidelines for the management of adults with congenital heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2008;118:e714-833.